These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 23259655

  • 21. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
    Di Munno O, Delle Sedie A.
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
    [Abstract] [Full Text] [Related]

  • 22. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C, Nolla JM, Valverde J, Narváez J, Corbella E, Pintó X.
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [Abstract] [Full Text] [Related]

  • 23. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [Abstract] [Full Text] [Related]

  • 24. Current use of glucocorticoids in patients with rheumatoid arthritis in Germany.
    Thiele K, Buttgereit F, Huscher D, Zink A, German Collaborative Arthritis Centres.
    Arthritis Rheum; 2005 Oct 15; 53(5):740-7. PubMed ID: 16208641
    [Abstract] [Full Text] [Related]

  • 25. The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.
    Cutolo M, Spies CM, Buttgereit F, Paolino S, Pizzorni C.
    Arthritis Res Ther; 2014 Nov 13; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25608624
    [Abstract] [Full Text] [Related]

  • 26. Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis.
    Hoes JN, Jacobs JW, Buttgereit F, Bijlsma JW.
    Nat Rev Rheumatol; 2010 Dec 13; 6(12):693-702. PubMed ID: 21119718
    [Abstract] [Full Text] [Related]

  • 27. Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients.
    Schroeder LL, Tang X, Wasko MC, Bili A.
    Rheumatol Int; 2015 Jun 13; 35(6):1059-67. PubMed ID: 25540049
    [Abstract] [Full Text] [Related]

  • 28. Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis.
    Nilsson AC, Christensen AF, Junker P, Lindegaard HM.
    Dan Med Bull; 2011 Apr 13; 58(4):A4257. PubMed ID: 21466765
    [Abstract] [Full Text] [Related]

  • 29. Modified release prednisone in patients with rheumatoid arthritis.
    Jacobs JW, Bijlsma JW.
    Ann Rheum Dis; 2010 Jul 13; 69(7):1257-9. PubMed ID: 20525834
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
    Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R.
    Lancet; 2008 Jan 19; 371(9608):205-14. PubMed ID: 18207016
    [Abstract] [Full Text] [Related]

  • 31. Circadian use of glucocorticoids in rheumatoid arthritis.
    Cutolo M, Sulli A, Pincus T.
    Neuroimmunomodulation; 2015 Jan 19; 22(1-2):33-9. PubMed ID: 25227591
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Old But Good: Modified-Release Prednisone in Rheumatoid Arthritis.
    Ursini F, Naty S, Bruno C, Grembiale RD.
    Rev Recent Clin Trials; 2017 Jan 19; 12(2):124-128. PubMed ID: 28356031
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec 19; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 40. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C, Buttgereit F.
    Mol Cell Endocrinol; 2013 Nov 05; 380(1-2):32-40. PubMed ID: 23403055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.